Related Experiment Video
Updated: Nov 11, 2025
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.5K
Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension
Dirk M Wuttge1, Anting L Carlsen2, Gabriel Teku3
1Department of Clinical Sciences Lund, Rheumatology, Lund University and Skåne University Hospital, Lund, Sweden.
Rheumatology (Oxford, England)
|March 30, 2021
Summary
Circulating microRNAs (miRNAs) in plasma may help identify SSc-associated pulmonary arterial hypertension (SSc-APAH). Specific miRNAs, like miR-20a-5p and miR-203a-3p, show altered levels in patients with SSc-APAH, potentially aiding early diagnosis.
Area of Science:
- Cardiovascular Research
- Pulmonary Medicine
- Molecular Biology
- Genetics
Background:
- Scleroderma (SSc) can lead to pulmonary arterial hypertension (SSc-APAH), a serious complication.
- Early detection of SSc-APAH is crucial for improving patient survival rates.
- Circulating microRNAs (miRNAs) are being investigated as potential biomarkers for diseases.
Purpose of the Study:
- To investigate the role of circulating miRNAs in the development of SSc-APAH.
- To identify specific miRNAs that can serve as early diagnostic markers for SSc-APAH.
Main Methods:
- Quantitative RT-PCR was used to measure mature miRNA abundance in plasma from 85 female patients with ACA-positive limited cutaneous SSc (lcSSc).
- Patients were divided into SSc-APAH (n=22) and SSc control (n=63) groups, matched for disease duration.
- Plasma miRNA levels were correlated with clinical data, and longitudinal samples were analyzed.
Main Results:
- Eleven miRNAs showed lower plasma levels, and four showed higher levels in SSc-APAH patients compared to controls.
- miR-20a-5p and miR-203a-3p levels were significantly different between groups (P=0.002) and correlated inversely with NT-pro-Brain Natriuretic Protein.
- Receiver operating characteristic analysis indicated potential diagnostic value for miR-21-5p and miR-20a-5p, individually or combined (AUC 0.69-0.83).
Conclusions:
- Circulating plasma miRNAs, particularly miR-20a-5p and miR-203a-3p, are linked to the occurrence of SSc-APAH in female patients with ACA-positive lcSSc.
- These miRNAs may serve as valuable biomarkers for early SSc-APAH detection.
- Further research is warranted to validate these findings and explore their clinical utility.
